The latest news about Lumendi
September 10, 2024
| DiLumen | EZ-Glide | Homepage | News | Press Release
Demonstrating Significant Time and Cost Savings in Colorectal ESD
DiLumen Reduced Total Procedure Time by 36.5%, Leading to an Average Cost Savings of $610.16 Per Patient and Improved En Bloc Resection Rate to 97.2%
July 27, 2023
| DiLumen EZ¹ | Grasper | Homepage | News | Press Release
EZ¹ successfully completes Customer Evaluation phase.
Lumendi Achieves Key Milestone with Completion of DiLumen EZ¹ Customer Evaluations, Setting the Stage for the Next Phase of DiLumen Product Innovation WESTPORT, CT – July 27, 2023 Lumendi, a… Continue reading EZ¹ successfully completes Customer Evaluation phase.
May 22, 2022
| DiLumen C¹ | DiLumen EZ¹ | Events | Homepage | News
A successful Digestive Disease Week (DDW) conference in San Diego
Since the company’s inception, we have accumulated over 100 DiLumen users worldwide. Half of these physicians have begun using our devices in the last 12 to 18 months. This year’s DDW was our first opportunity in three years to present Lumendi and our significantly enhanced DiLumen platform to users and industry.
February 10, 2022
| Homepage | News | Press Release
Lumendi Reports Successful Completion Of Dilumen™ Eip First-in-human Trials
LUMENDI REPORTS SUCCESSFUL COMPLETION OF DILUMEN™ EIP FIRST-IN-HUMAN TRIALS Primary Study Endpoint Reached with no Serious Adverse Events WESTPORT, CONNECTICUT, November 16, 2017 – Connecticut-based medical device innovator Lumendi,… Continue reading Lumendi Reports Successful Completion Of Dilumen™ Eip First-in-human Trials
December 9, 2021
| Homepage | Products
30% of surgical interventions are unnesessary
Dr. Peter Johann, CEO & Founder of Lumendi and Prof. Bauerfeind discussed how treatment methods such as EMR and ESD can be made more accessible to patients. Prof. Bauerfeind: "Sometimes these treatments… Continue reading 30% of surgical interventions are unnesessary
May 6, 2021
| Homepage | News | Products
Introducing EZ Glide in Europe
Many studies have documented that an endoscopic approach for ESD is a safer and less expensive alternative to removing these polyps, leading to fewer postoperative complications and shorter hospital stays.
March 29, 2021
| Homepage | News | Press Release | Uncategorized
Lumendi Introduces EZ Glide Hydrophilic Coating for Its DiLumen Endoluminal Interventional Platform (EIP™)
Lumendi Platforms to be Discussed in Investor’s Webcast 31 March 2021 with Panel of Clinical Experts New EZ Glide, activated by water or saline, improves endoscopic performance of the DiLumen… Continue reading Lumendi Introduces EZ Glide Hydrophilic Coating for Its DiLumen Endoluminal Interventional Platform (EIP™)